Rapid Dose Therapeutics RDTCF Stock
Rapid Dose Therapeutics Price Chart
Rapid Dose Therapeutics RDTCF Financial and Trading Overview
Rapid Dose Therapeutics stock price | 0.0080 USD |
Previous Close | 0.19 USD |
Open | 0.04 USD |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 0.04 - 0.04 USD |
52 Week Range | 0.0004 - 0.2 USD |
Volume | 1.5K USD |
Avg. Volume | 1.23K USD |
Market Cap | 3.83M USD |
Beta (5Y Monthly) | 1.126151 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.03 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
RDTCF Valuation Measures
Enterprise Value | 21.67M USD |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 5.92535 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 33.509 |
Enterprise Value/EBITDA | -4.456 |
Trading Information
Rapid Dose Therapeutics Stock Price History
Beta (5Y Monthly) | 1.126151 |
52-Week Change | -74.81% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.2 USD |
52 Week Low | 0.0004 USD |
50-Day Moving Average | 0.09 USD |
200-Day Moving Average | 0.03 USD |
RDTCF Share Statistics
Avg. Volume (3 month) | 1.23K USD |
Avg. Daily Volume (10-Days) | 1.28K USD |
Shares Outstanding | 103.57M |
Float | 91.64M |
Short Ratio | N/A |
% Held by Insiders | 16.36% |
% Held by Institutions | 0% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | February 28, 2022 |
Most Recent Quarter (mrq) | November 30, 2022 |
Next Fiscal Year End | February 28, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | -808.042% |
Gross Margin | 19.10% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -76.36% |
Return on Equity (ttm) | -913.82% |
Income Statement
Revenue (ttm) | 646.75K USD |
Revenue Per Share (ttm) | 0.006 USD |
Quarterly Revenue Growth (yoy) | -33.20% |
Gross Profit (ttm) | 1.21M USD |
EBITDA | -4863749 USD |
Net Income Avi to Common (ttm) | -9434980 USD |
Diluted EPS (ttm) | -0.07 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 26.37K USD |
Total Cash Per Share (mrq) | 0 USD |
Total Debt (mrq) | 2.02M USD |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 0.163 |
Book Value Per Share (mrq) | -0.014 |
Cash Flow Statement
Operating Cash Flow (ttm) | -874523 USD |
Levered Free Cash Flow (ttm) | 779.81K USD |
Profile of Rapid Dose Therapeutics
Country | United States |
State | ON |
City | Burlington |
Address | 1121 Walkers Line |
ZIP | L7N 2G4 |
Phone | N/A |
Website | https://rapid-dose.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Rapid Dose Therapeutics Corp., a life sciences company, provides drug delivery technologies designed to enhance outcomes in Canada. The company offers QuickStrip/PharmaStrip, an oral fast-dissolving drug delivery system to rapidly release active ingredients into the blood stream, such as pharmaceuticals, emulsified oils, and over-the-counter medicines; QuickStrip energy to deliver energizing caffeine; QuickStrip B12 to deliver vitamin B12 in the system; and QuickStrip sleep that delivers melatonin in the system, as well as dental products. It also provides product innovation, production, and consultation services to the nutraceutical, cannabis healthcare, and pharmaceutical manufacturing industries. The company is headquartered in Burlington, Canada.
Q&A For Rapid Dose Therapeutics Stock
What is a current RDTCF stock price?
Rapid Dose Therapeutics RDTCF stock price today per share is 0.0080 USD.
How to purchase Rapid Dose Therapeutics stock?
You can buy RDTCF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Rapid Dose Therapeutics?
The stock symbol or ticker of Rapid Dose Therapeutics is RDTCF.
Which industry does the Rapid Dose Therapeutics company belong to?
The Rapid Dose Therapeutics industry is Biotechnology.
How many shares does Rapid Dose Therapeutics have in circulation?
The max supply of Rapid Dose Therapeutics shares is 128.44M.
What is Rapid Dose Therapeutics Price to Earnings Ratio (PE Ratio)?
Rapid Dose Therapeutics PE Ratio is now.
What was Rapid Dose Therapeutics earnings per share over the trailing 12 months (TTM)?
Rapid Dose Therapeutics EPS is -0.03 USD over the trailing 12 months.
Which sector does the Rapid Dose Therapeutics company belong to?
The Rapid Dose Therapeutics sector is Healthcare.